Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für Informatik     Collection: Computational Biology and Applied Algorithmics     Display Documents



  history
ID: 356613.0, MPI für Informatik / Computational Biology and Applied Algorithmics
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of restistance to nonnucleoside inhibitors
Authors:Ceccherini-Silberstein, Francesca; Svicher, Valentina; Sing, Tobias; Artese, Anna; Santoro, Maria Mercedes; Forbici, Federica; Bertoli, Ada; Alcaro, Stefano; Palamara, Guido; Monforte, Antonella d'Arminio; Balzarini, Jan; Antinori, Andrea; Lengauer, Thomas; Perno, Carlo Federico
Language:English
Date of Publication (YYYY-MM-DD):2007
Title of Journal:Journal of Virology
Volume:81
Issue / Number:20
Start Page:11507
End Page:11519
Copyright:Access to full-text articles back to the dates of journal origin for ASM's
online primary-research journals is FREE 4 months after an issue's publication.
For example, on September 1, the full-text articles from the previous May issue
become free.
http://journals.asm.org/subscriptions/freebackissues.shtml
08/02/08
Review Status:Peer-review
Audience:Experts Only
Intended Educational Use:No
Abstract / Description:Resistance to antivirals is a complex and dynamic phenomenon that involves more
mutations than are currently known. Here, we characterize 10 additional
mutations (L74V, K101Q, I135M/T, V179I, H221Y, K223E/Q, and L228H/R) in human
immunodeficiency virus type 1 (HIV-1) reverse transcriptase which are involved
in the regulation of resistance to nonnucleoside reverse transcriptase
inhibitors (NNRTIs). These mutations are strongly associated with NNRTI failure
and strongly correlate with the classical NNRTI resistance mutations in a data
set of 1,904 HIV-1 B-subtype pol sequences from 758 drug-naïve patients, 592
nucleoside reverse transcriptase inhibitor (NRTI)-treated but NNRTI-naïve
patients, and 554 patients treated with both NRTIs and NNRTIs. In particular,
L74V and H221Y, positively correlated with Y181C, were associated with an
increase in Y181C-mediated resistance to nevirapine, while I135M/T mutations,
positively correlated with K103N, were associated with an increase in
K103N-mediated resistance to efavirenz. In addition, the presence of the I135T
polymorphism in NNRTI-naïve patients significantly correlated with the
appearance of K103N in cases of NNRTI failure, suggesting that I135T may
represent a crucial determinant of NNRTI resistance evolution. Molecular
dynamics simulations show that I135T can contribute to the stabilization of the
K103N-induced closure of the NNRTI binding pocket by reducing the distance and
increasing the number of hydrogen bonds between 103N and 188Y. H221Y also
showed negative correlations with type 2 thymidine analogue mutations (TAM2s);
its copresence with the TAM2s was associated with a higher level of zidovudine
susceptibility. Our study reinforces the complexity of NNRTI resistance and the
significant interplay between NRTI- and NNRTI-selected mutations. Mutations
beyond those currently known to confer resistance should be considered for a
better prediction of clinical response to reverse transcriptase inhibitors and
for the development of more efficient new-generation NNRTIs.
Last Change of the Resource (YYYY-MM-DD):2008-03-07
External Publication Status:published
Document Type:Article
Communicated by:Thomas Lengauer
Affiliations:MPI für Informatik/Computational Biology and Applied Algorithmics
Identifiers:ISSN:0022-538X
DOI:10.1128/JVI.00303-07
LOCALID:C12573CC004A8E26-142B4822A3CC878EC12573CC003737EA-...
Full Text:
You have privileges to view the following file(s):
Ceccherini.pdf  [4,00 Kb] [Comment:file from upload service]  
 
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.